Reviva Pharmaceuticals Holdings RVPH
OTC RVPH
$0.47 -0.03 (-6.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Reviva Pharmaceuticals Holdings (RVPH) Cash from Financing Activities (2018 - 2026)

Updated

Reviva Pharmaceuticals Holdings (RVPH) reported Cash from Financing Activities of -$184,869 for Q2 2026, compared with $10.09 million a year earlier.

Analysis

Reviva Pharmaceuticals Holdings (RVPH) Cash from Financing Activities (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Reviva Pharmaceuticals Holdings' Cash from Financing Activities came in at $26.83 million, down 12.7% year-over-year; for FY2025, it came in at $25.56 million, up 8.1% from FY2024.

  • Cash from Financing Activities has a five-year compound annual growth rate of 14.8% (FY2020 to FY2025).
  • By year, Cash from Financing Activities came in at $23.65 million in FY2024 (-28.7%), $33.17 million in FY2023 (+325.7%) and $7.79 million in FY2022.
  • The Q2 2026 figure ranks as the lowest quarterly Cash from Financing Activities since Q1 2020.
  • Year over year, Cash from Financing Activities gained in two of the last five quarters, with growth averaging 42.9%.
  • The high point for year-over-year Cash from Financing Activities in five years was Q2 2025 (growth of 276.3%); the low point was Q1 2025 (a decline of 97.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $11.55 million (Q1 2026), $7.05 million (Q4 2025) and $8.41 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Reviva Pharmaceuticals Holdings 6.16 Mn 6.16 Mn - -184,869.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -184,869.00
Mar 31, 2026 11.55 Mn
Dec 31, 2025 7.05 Mn
Sep 30, 2025 8.41 Mn
Jun 30, 2025 10.09 Mn
Mar 31, 2025 7,271.00
Dec 31, 2024 17.02 Mn
Sep 30, 2024 3.62 Mn
Jun 30, 2024 2.68 Mn
Mar 31, 2024 332,000.00
Dec 31, 2023 27.27 Mn
Jun 30, 2023 5.21 Mn
Mar 31, 2023 687,093.00
Dec 31, 2022 18,563.00
Sep 30, 2022 7.77 Mn
Mar 31, 2022 70.00
Dec 31, 2021 98,481.00
Jun 30, 2021 31.50 Mn
May 31, 2020 -26.61 Mn
May 31, 2018 18,341.00
API Access

Reviva Pharmaceuticals Holdings Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RVPH&period=max&api_key=YOUR_API_KEY